Localization of Hepatitis C Virus Using Reverse Transcriptase Fluorescence In Situ 5′ Nuclease Assay

Author(s):  
Bruce K. Patterson
1999 ◽  
Vol 12 (3) ◽  
pp. 233-241 ◽  
Author(s):  
Dominique Bettinger ◽  
Christiane Mougin ◽  
Brigitte Fouqué ◽  
Bernadette Kantelip ◽  
Jean Philippe Miguet ◽  
...  

1998 ◽  
Vol 46 (5) ◽  
pp. 653-660 ◽  
Author(s):  
Francine M. Walker ◽  
Marie-Christine Dazza ◽  
Marie-Christine Dauge ◽  
Olivier Boucher ◽  
Christophe Bedel ◽  
...  

Hepatitis C virus (HCV) detection in the livers of chronically infected patients remains a debatable issue. We used immunohistochemistry, in situ hybridization (ISH) alone or after microwave heating with FITC-labeled probes, RT-PCR with unlabeled primers followed by ISH (RT-PCR-ISH), and in situ RT-PCR with FITC-labeled primers (in situ RT-PCRd) to localize the virus in 38 liver biopsy specimens from 21 chronically infected HCV patients treated with interferon-α (IFN-α). Biopsies were taken at the beginning and end of IFN-α treatment and 1 year later. Results were compared with that of HCV-PCR in serum. RT-PCR-ISH and in situ RT-PCRd showed HCV signal in all liver biopsies even in responders with seronegative HCV PCR. This signal was intranuclear, diffuse, or peripheral, in hepatocytes, bile ductule cells, and lymphocytes. Cytoplasmic signals were occasionally observed. Whereas the percentage of labeled hepatocytes remained constant, the number of labeled lymphoid follicles decreased after INF-α therapy. Immunohistochemistry resulted in the same pattern of positivity but it was weaker and inconstant. This study indicates the persistency of HCV latency in IFN-α responders 1 year after IFN-α treatment cessation, a finding that certainly deserves confirmation.


2008 ◽  
Vol 13 (4) ◽  
pp. 203-208 ◽  
Author(s):  
Yujiro Tanaka ◽  
Nobuyuki Enomoto ◽  
Shigeru Kojima ◽  
Liang Tang ◽  
Mieko Goto ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document